Edgewise Therapeutics (EWTX) Return on Capital Employed [ROCE] (2021 - 2026)
Edgewise Therapeutics (EWTX) posted Return on Capital Employed [ROCE] of -46.57% for Q2 2026, down 12.54 percentage points from -34.03% a year earlier and down 7.67 percentage points from the prior quarter.
Powered by 
Analysis
Edgewise Therapeutics (EWTX) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends
For FY2025, Edgewise Therapeutics' Return on Capital Employed [ROCE] came in at -38.88%, up 1.89 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a four-year change of -17.01 percentage points (FY2021 to FY2025).
- In prior years, Edgewise Therapeutics' Return on Capital Employed [ROCE] was -40.77% in FY2024 (-6.82 pp), -33.95% in FY2023 (-10.81 pp), -23.15% in FY2022 (-1.28 pp) and -21.86% in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2021.
- On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last six quarters, with an average year-over-year change of -3.39 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2024, with a gain of 4.38 percentage points; the weakest was Q4 2023, with a drop of 16.86 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -38.90% (Q1 2026), -35.40% (Q4 2025) and -31.38% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Edgewise Therapeutics | 5.09 Bn | 2.32 Bn | - | -22.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -22.13% |
| Jun 30, 2026 | -46.57% |
| Mar 31, 2026 | -38.90% |
| Dec 31, 2025 | -35.40% |
| Sep 30, 2025 | -31.38% |
| Jun 30, 2025 | -34.03% |
| Mar 31, 2025 | -37.83% |
| Dec 31, 2024 | -33.42% |
| Sep 30, 2024 | -29.28% |
| Jun 30, 2024 | -25.91% |
| Mar 31, 2024 | -28.55% |
| Dec 31, 2023 | -37.02% |
| Sep 30, 2023 | -33.67% |
| Jun 30, 2023 | -28.20% |
| Mar 31, 2023 | -23.99% |
| Dec 31, 2022 | -20.15% |
| Sep 30, 2022 | -20.53% |
| Jun 30, 2022 | -22.36% |
| Mar 31, 2022 | -19.03% |
| Dec 31, 2021 | -15.47% |
API Access
Edgewise Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EWTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "EWTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EWTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();